Usefulness of 18F-fluorodeoxyglucose positron emission tomography scan in the assessment of periprosthetic collections: report of 2 cases with opposite management

Ann Vasc Surg. 2014 Apr;28(3):738.e1-6. doi: 10.1016/j.avsg.2013.07.030. Epub 2013 Nov 8.

Abstract

Vascular prosthetic infection is a rare but serious complication of vascular surgery that requires rapid diagnosis and treatment. It is associated with high rates of amputation and death. The diagnosis is difficult when faced with a chronic nonspecific clinical presentation. We report 2 cases showing the diagnostic usefulness of positron emission tomography (PET). In 1 case, PET excluded with certainty the septic character of a periprosthetic collection fistulized with the skin by showing a periprosthetic fixation insufficient to diagnose an infection. In the other case, it confirmed the prosthetic infection in association with an evocative clinical picture by revealing a pathologic periprosthetic hyperfixation. PET scan therefore drew aside the diagnosis of prosthetic infection faced with a mild clinical and paraclinical presentation in the first case, and made it possible to pose it with certainty in the second case. This examination made it possible to save valuable time in 1 case and to elucidate the periprosthetic collection in the other case. Therefore, the rule of surgical explantation of any prosthesis with flow or periprosthetic collection is no more univocal.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Blood Vessel Prosthesis / adverse effects*
  • Blood Vessel Prosthesis Implantation / adverse effects*
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Device Removal
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Predictive Value of Tests
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / surgery
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Reoperation
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18